Exclusive

Publication

Byline

Location

UPG 303 Pty Ltd Issues ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’

Australia, Aug. 31 -- UPG 303 Pty Ltd (ACN: 653393018) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More


UPG 304 Pty Ltd Issues ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’

Australia, Aug. 31 -- UPG 304 Pty Ltd (ACN: 653393027) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More


UPG 305 Pty Ltd Issues ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’

Australia, Aug. 31 -- UPG 305 Pty Ltd (ACN: 653393036) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More


Clinical Trial: Construction and application of a smart aging exercise promotion system in community parks (Japan)

Tokyo, Aug. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062705) titled 'Individualized Prescription Using Outdoor Fitness Equipment: A Two-Phase In... Read More


Clinical Trial: The Effect of Improved Temperature Sensation by Menthol Application on Cognitive Function During Hyperthermia (Japan)

Tokyo, Aug. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062701) titled 'The Effect of Improved Temperature Sensation by Menthol Application on Cogn... Read More


Clinical Trial: Pembrolizumab dose-optimization study with Regression discontinuity design In patients with non-small cell lung Cancer to avert Excessive toxicity and cost (PRICE): Sub-study (Japan)

Tokyo, Aug. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062700) titled 'Pembrolizumab dose-optimization study with Regression discontinuity design ... Read More


UPG 101 Pty Ltd Issues ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’

Australia, Aug. 31 -- UPG 101 Pty Ltd (ACN: 636508686) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More


UPG 102 Pty Ltd Issues ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’

Australia, Aug. 31 -- UPG 102 Pty Ltd (ACN: 636508480) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More


UPG 103 Pty Ltd Issues ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’

Australia, Aug. 31 -- UPG 103 Pty Ltd (ACN: 636508711) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More


UPG 104 Pty Ltd Issues ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’

Australia, Aug. 31 -- UPG 104 Pty Ltd (ACN: 636508800) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (MEETING ONLY) - 436E(3)(b)’ on Aug. 27. The following are oth... Read More